Category
144 releases
From millions of molecular measurements to clinically supported therapeutic predictions, Differentia is building AI-powered disease environments for…
New medical school combines academic excellence, early clinical experience, and comprehensive student support to prepare the next generation of…
Late-breaking data presented at TCT 2026 and published simultaneously in JACC: Cardiovascular Interventions show durable benefit with MagicTouch PTA,…
Moberg Pharma AB (OMX: MOB) today announced that the United States Patent and Trademark Office (USPTO) has granted a patent relating to an improved…
Sobi® (STO: SOBI) today announced that six abstracts covering pozdeutinurad (AR882), nanoencapsulated sirolimus plus pegadricase (NASP) and…
Phase 3 of the 140th Canton Fair, held from October 31 to November 4, centers on the theme "Better Life." As health remains central to high quality…
Renewed initiative expands rural agencies' access to Clinical Intelligence, medication verification, training and medical equipment DAVIE, Fla., Nov.…
ICP DAS-BMP (Biomedical Polymers), a Taiwan-based manufacturer and supplier of medical-grade TPU (thermoplastic polyurethane), will exhibit at…
Marks Ultima's first major win to support a national-scale clinical whole genome sequencing initiative NPM Phase III will leverage Ultima's UG200…
SG-INSIGHT study will extend whole-genome sequencing to nearly 1 in 10 Singapore residents, generating evidence to inform how precision medicine…
Third Quarter 2026 Total Revenues Increased 32% Y/Y to $1.025 billion; Growth Driven by 44% Increase in Metabolic Conditions Y/Y, and 12% Increase in…
ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that…
Eloxx Pharmaceuticals, Inc. (Nasdaq: ELOX), a clinical-stage biopharmaceutical company developing exaluren for the treatment of rare kidney diseases,…
– Broad commercial execution drives record quarterly revenues of $1.2 billion (+10% YoY) – – Company raises full year 2026 total revenue guidance – –…
INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from…
INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from…
Travere Therapeutics Reports Third Quarter 2026 Financial Results
BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced that Novartis Pharma AG has notified BioArctic that it has decided to terminate the…
Both post-implant monotherapies in the trial achieved non-inferiority compared to dual anti-platelet therapy (DAPT) supporting the potential to…
Connects AI visibility audits with prioritized actions to help biopharma teams improve how brands and disease education content are represented in…
